Salient Surgical Technologies Newswire (Page 9)

Salient Surgical Technologies Newswire (Page 9)

Comprehensive Real-Time News Feed for Salient Surgical Technologies. (Page 9)

Results 161 - 180 of 7,109 in Salient Surgical Technologies

  1. Mystery Glitch Took Out Medtronic's Computers Last WeekRead the original story

    Jun 25, 2017 | BioSpace

    A mystery snafu reportedly took out the global computer systems at Medtronic last week, but there's no sign that the problem came from outside the company. The Fridley, Minn.-based medical device titan had restored some of the system by June 22, a spokesman told the Minneapolis Star Tribune, and the interruption is not expected to have a material impact on finances as the company investigates the cause.

    Comment?

  2. $7.48 Billion in Sales Expected for Medtronic PLC (MDT) This QuarterRead the original story w/Photo

    Jun 25, 2017 | AmericanBankingNews.com

    Equities analysts forecast that Medtronic PLC will report sales of $7.48 billion for the current fiscal quarter, according to Zacks Investment Research . Eight analysts have made estimates for Medtronic PLC's earnings.

    Comment?

  3. American National Insurance Co. TX Has $6,188,000 Stake in Medtronic PLCRead the original story w/Photo

    Jun 24, 2017 | IntersportsWire

    American National Insurance Co. TX continued to hold its stake in shares of Medtronic PLC during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission .

    Comment?

  4. Somewhat Positive Media Coverage Very Likely to Impact Medtronic PLC (MDT) Share PriceRead the original story w/Photo

    Jun 23, 2017 | IntersportsWire

    Media coverage about Medtronic PLC has trended somewhat positive recently, Accern reports. The research group rates the sentiment of media coverage by analyzing more than twenty million blog and news sources.

    Comment?

  5. Medtronic PLC (MDT) Shares Sold by Appleton Partners Inc. MARead the original story w/Photo

    Jun 23, 2017 | IntersportsWire

    Appleton Partners Inc. MA reduced its position in shares of Medtronic PLC by 16.1% during the first quarter, according to its most recent disclosure with the SEC. The fund owned 74,648 shares of the medical technology company's stock after selling 14,337 shares during the period.

    Comment?

  6. Sequoia Financial Advisors LLC Has $376,000 Stake in Medtronic PLCRead the original story w/Photo

    Jun 23, 2017 | IntersportsWire

    Sequoia Financial Advisors LLC reduced its position in shares of Medtronic PLC by 1.4% during the first quarter, according to its most recent disclosure with the SEC. The fund owned 4,667 shares of the medical technology company's stock after selling 67 shares during the period.

    Comment?

  7. Medtronic Announces 7 Percent Increase In Cash DividendRead the original story

    Jun 22, 2017 | BioSpace

    This would translate into an annual amount of $1.84 per ordinary share, or a dividend per share payout ratio of 40 percent of prior fiscal year non-GAAP diluted earnings per share. Today's announcement marks the 40th consecutive year of an increase in the dividend payment for Medtronic, a constituent of the S&P 500 Dividend Aristocrats index.

    Comment?

  8. Medtronic PLC (MDT) Position Maintained by NJ State Employees Deferred Compensation PlanRead the original story w/Photo

    Jun 22, 2017 | IntersportsWire

    NJ State Employees Deferred Compensation Plan held its position in Medtronic PLC during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission . The fund owned 20,000 shares of the medical technology company's stock at the end of the first quarter.

    Comment?

  9. North America Biopsy Devices Market 2016 Trends, Growth and Forecast to 2021Read the original story

    Jun 22, 2017 | Emailwire.com

    North America Biopsy Devices Market by Product, by Type, by Application, and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts Market Data Forecast recently published a report on the North America Biopsy Devices Market which estimates the market which was worth $527 million in 2016 and is expected to be growing at a CAGR of 6.82%, to reach $733 million by 2021 during the forecast period from 2016 to 2021. For most types of cancer, a biopsy is the main way doctors diagnose cancer.

    Comment?

  10. North America Interventional Neurology/Neurovascular devices Market...Read the original story

    Jun 22, 2017 | Emailwire.com

    North America Interventional Neurology/Neurovascular devices Market by Technology, Product End-users and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts Market Data Forecast recently published a report on the North America Interventional Neurology/Neurovascular devices Market which estimates the market to grow from USD 739.47 Billion from 2016 to USD 1,111.91 million with a high CAGR of 8.5%.Neurology is a branch that deals with the disorders of nervous system and brain. Interventional neurology deals with the diagnosis, treatment of all categories conditions and diseases involving the peripheral and central nervous system.

    Comment?

  11. Oppenheimer Holdings Weighs in on Medtronic plc.'s Q1 2018 EarningsRead the original story w/Photo

    Jun 21, 2017 | IntersportsWire

    Investment analysts at Oppenheimer Holdings issued their Q1 2018 earnings estimates for shares of Medtronic plc. in a research report issued to clients and investors on Friday.

    Comment?

  12. Medtronic PLC (MDT) Now Covered by Goldman Sachs Group IncRead the original story w/Photo

    Jun 21, 2017 | IntersportsWire

    The brokerage issued a neutral rating and a $87.00 target price on the medical technology company's stock. Several other research analysts have also recently weighed in on the company.

    Comment?

  13. United Fire Group Inc. Maintains Stake in Medtronic PLCRead the original story w/Photo

    Jun 21, 2017 | IntersportsWire

    United Fire Group Inc. maintained its position in Medtronic PLC during the first quarter, according to its most recent filing with the Securities and Exchange Commission . The institutional investor owned 25,000 shares of the medical technology company's stock at the end of the first quarter.

    Comment?

  14. Medtronic plc. (MDT) Earns "Buy" Rating from CIBCRead the original story w/Photo

    Jun 20, 2017 | IntersportsWire

    A number of other research firms have also commented on MDT. Vetr lowered Medtronic plc.

    Comment?

  15. Medtronic plc. (MDT) Stock Rating Lowered by Zacks Investment ResearchRead the original story w/Photo

    Jun 20, 2017 | IntersportsWire

    According to Zacks, "Ahead of its fourth quarter fiscal 2017 result, we believe Medtronic will do well banking on strong performances of major business groups with sustainability across all regions. Earlier, the company observed solid growth trend in the U.S. on healthy global acceptance of its therapies.

    Comment?

  16. Anti-Snoring Devices and Snoring Surgery Market Driven by Integration of IoT and NanotechnologyRead the original story w/Photo

    Jun 20, 2017 | SBWire

    Anti-Snoring Devices and Surgery Market: Snapshot The global anti-snoring devices and surgery market is ripe for disruption. There are numerous factors pointing toward this imminent change.

    Comment?

  17. Medtronic Release: New Data Reveal Medtronic CRT Devices Improve...Read the original story

    Jun 19, 2017 | BioSpace

    June 20, 2017 - Medtronic plc today announced new data showing that use of its cardiac resynchronization therapy devices - with its proprietary AdaptivCRT and EffectiveCRT algorithms - results in lower healthcare system costs, and improves therapy delivery in heart failure patients who also have atrial fibrillation . The results of three analyses were presented at the EHRA EUROPACE-CARDIOSTIM 2017 in Vienna.

    Comment?

  18. New Data Reveal Medtronic CRT Devices Improve Therapy Delivery And Reduce Healthcare CostsRead the original story

    Jun 19, 2017 | BioSpace

    June 20, 2017 - Medtronic plc today announced new data showing that use of its cardiac resynchronization therapy devices - with its proprietary AdaptivCRT and EffectiveCRT algorithms - results in lower healthcare system costs, and improves therapy delivery in heart failure patients who also have atrial fibrillation . The results of three analyses were presented at the EHRA EUROPACE-CARDIOSTIM 2017 in Vienna.

    Comment?

  19. Bedrijfstakpensioenfonds Voor DE Media PNO Has $1,152,000 Stake in Medtronic PLCRead the original story w/Photo

    Jun 20, 2017 | IntersportsWire

    Bedrijfstakpensioenfonds Voor DE Media PNO held its stake in Medtronic PLC during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 14,300 shares of the medical technology company's stock at the end of the first quarter.

    Comment?

  20. North America Spinal Cord Stimulation (SCS) Market by Application, Product Type and End usersRead the original story

    Jun 20, 2017 | Emailwire.com

    Based on Application, the market is segmented into DDD, FBS, Unsuccessful Disk Surgery, CRPS, Multiple Back Operations, and lumbar Adhesive Arachnoiditis, by Product Type , by End users, by End users Spinal cord stimulation is a therapy that masks pain signals before they reach the brain. A small device, similar to a pacemaker, is implanted in the body to deliver electrical pulses to the spinal cord.

    Comment?